Atlas Trials

CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke

Clinical trial NCT06078215 · UNKNOWN

Trial details

NCT number
NCT06078215
Sponsor
Poznan University of Medical Sciences
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Ischemic Stroke
Start date
2023-01-10
Primary completion
2025-01-31
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.